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Abstract 
Trypsin-modulating oostatic factor (TMOF) and two analogues of TMOF have been sucessfully synthesised via solid-phase 
peptide synthesis (SPPS) method. The synthesis was based on Fmoc strategy and employed chlorotrityl resin as solid support. A 
combination of N,N-diisopropylcarbodiimide (DIC) and ethyl-2-cyano-2-(hydroxyimino)acetate (oxyma) was proven to be the 
best coupling reagent in the synthesis. Fmoc-aspartic acid and Fmoc-tyrosine of TMOF were added onto peptidyl resin as t-Bu-
protected amino acids. The t-Bu group was removed following the resin cleavage by using TFA cocktail. The t-Bu-free peptides 
were purified by using reversed-phase flash column chromatography with octadecyl silane (ODS)-functionalized silica as 
stationary phase. All peptides were characterized by using ESI-MS and their purity were checked by using thin layer 
chromatography. 
 
 
Keywords: TMOF; solid-phase peptide synthesis; DIC/Oxyma; Fmoc strategy 
1. Introduction 
Trypsin-modulating oostatic factor (TMOF) (Figure 1), isolated from ovaries of the female Aedes aegypty, was 
found to have an insecticidal activity towards the mosquito larvae1,2. TMOF is a decapeptide (YDPAPPPPPP) that 
inhibits the trypsin- or chemotrypsin-like enzyme biosynthesis in mosquito. When TMOF is applied to mosquito 
larvae, trypsin biosynthesis in the midgut of larvae or adults will be ceased3.  
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Trypsin is needed by mosquitoes to digest food for egg development. Thus, the injection of TMOF into the 
mosquito larvae can arrest larval growth and starve the insects to death. In his review, Borovsky stated that TMOF is 
potential as a future biorationale larviside1. TMOF is considered to be environmentally friendly and effective. It is 
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also deemed that TMOF can replace current resistance insecticides. Due to the properties of TMOF, research on 
TMOF are of interest. 
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Fig. 1.  Structure of TMOF (YDPAPPPPPP). 
 
The lepidopteran Crocidolomia pavonana is known as cabbage pest in the agriculture field. It is becoming 
enemies for farmers including farmers in Indonesia. Currently, we are interested in studying TMOF and analogues 
for their biological properties against C. pavonana. Since some lepidoptera such as Heliothis virescens and Plutella 
xylostella have been found to use trypsin to digest food3. The study is aimed to test if TMOF could control trypsin 
biosynthesis in lepidopteran C. pavonana. 
Most studies of TMOF took advantage of TMOF that was isolated from the female ovary of Aedes aegypty, 
while the chemical synthesis of TMOF itself was rarely revealed. To provide the TMOF for this study, the chemical 
synthesis of TMOF and some analogues will be described in this paper.  
Solid-phase peptide synthesis method was chosen over solution-phase peptide synthesis. Total synthesis of 
peptides in solution phase has been clearly shown to be challenging and time consuming4,5,6,7,8,9,10, One of the 
disadvantages of synthesis in solution phase is the large amount of starting materials required. Several steps are 
involved including preparation of the residues, synthesis of fragments and the linear peptide which can all result in 
low yields. Most of the time, purification between steps is also required which also impacts the yield. Solid-phase 
peptide synthesis, pioneered by Merrifield11, is a useful method to overcome some of the problems inherent in 
solution chemistry and has been applied to successfully synthesise several peptides, cyclopeptides, depsipeptides 
and cyclodepsipeptides12,13. TMOF was prepared on chlorotrityl resin. This selection was based on the fact that the 
resin does not have a tendency towards diketopiperazine formation particularly during the attachment of the first two 
residues on resin. This is particularly the case when proline is present as the C terminus of the peptide. Chlorotrityl 
resin has also been shown to be able to avoid extensive racemization during the attachment of the first amino acid 
particularly in Fmoc-based peptide synthesis14. The synthesis was based on Fmoc strategy and employed 
DIC/oxyma as coupling reagent. DIC (N,N′-diisopropylcarbodiimide) is one of carbodiimide reagents designed to 
prevent the formation of N-acylurea15. The use of DIC is preferred to that of dicyclohexylcarbodiimide (DCC) 
because the urea generated by the former is soluble in DMF16. The reagent is mostly employed with a combination  
with some additives. Oxyma (ethyl 2-cyano-2-(hydroxy-imino)acetate) as the coupling addive is chosen since it 
shows superiority over famous additive HOBt (N-hydroxybenzotriazole) in avoiding racemisation. Oxyma can also 
give coupling efficiency for the carbodiimide approach17.  
 
2. Experimental 
2.1. Resin loading 
To 2-chlorotrityl resin (1.0-1.6 mmol) was added dry dichloromethane (5 mL). The resin was shaken for 5 min 
and then filtered. A solution of Fmoc-L-proline (0.50 mmol) that was previously treated with dry dichloromethane (4 
mL) and N,N-diisopropylethylamine (DIPEA) (1.25 mmol) was added onto resin. The mixture was shaken for 30 
min, filtered, and then washed with dimethylformamide (DMF) (2 x 2 min). A mixture of 
dichloromethane:methanol:DIPEA (80:15:5/5 mL) was added and the mixture was shaken for another 10 min. The 
latter step was undertaken in two cycles. The resin was then filtered and washed successively with 3 x 2.5 mL DMF 
and 3 x 2.5 mL dichloromethane. The resin was dried in vacuo for 30 min by a stream of air to obtain dry Fmoc-
propyl resin.  
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2.2. Fmoc deprotection 
Fmoc-peptidyl resin was shaken with 25% dry piperidine in dry DMF (10 mL) for 30 min. The resin was then 
filtered and washed with DMF and dichloromethane successively. The reaction was monitored by thin layer 
chromatography where the successful Fmoc removal was shown with the absence of the compound spot on the thin 
layer chromatography (TLC) plate under 254 nm Ultra Violet (UV) light. 
 
2.3. DIC/Oxyma-mediated coupling 
Fmoc-amino acid (4 eq.) and oxyma (4 eq.) were weighed in a dry vial and dissolved in a small amount of DMF. 
DIC (4 eq.) was then added until the solution turns yellow. The solution was added onto dry peptidyl resin  and 
shaken for 30 min. Coupling effectivity was tested by chloranil test. A positive result is shown by dark blue to green 
beads and a negative result is shown by colorless to yellowish beads. If the coupling was done, the peptidyl resin 
was washed with DMF and dichloromethane successively.  
 
2.4. Resin cleavage 
TMOF and DPAP: To the peptidyl-trichlorotrityl resin was added a cleavage cocktail of trifluoroacetic acid 
(TFA):1,2-ethanedithiol (EDT):water (95:2.5:2.5/10 mL). The yellow resin turned bright red. The resin was then 
shaken for 1 h and then filtered. The resin was washed subsequently with further cleavage cocktail (10 mL x 2) and 
dry dichloromethane (10 mL x 2). The combined solution was evaporated and the resulting residue was dissolved in 
acetonitrile:water (1:1, 10 mL). The crude solution (1 mg/1mL in 50% acetonitrile in water) was subjected to 
analytical Reversed Phase High Performance Liquid Chromatography (RP-HPLC) and monitored at 240 nm. The 
purification was undertaken on open column chromatography using octadesylsilane-coated silica and the purity of 
the peptide was tested by thin layer chromatography. The purity of the product will be checked by analytical RP-
HPLC and characterized by mass spectrometry. 
PPPP: the protocol was the same, however the cocktail of trifluoroacetic acid:1,2-ethanedithiol (EDT):water 
(95:2.5:2.5/10 mL) was replaced by a cocktail of TFA:dichloromethane (2:8) 
 
2.5. Chloranil test general procedure18 
The stock solutions are kept in a fridge for a maximum of one month. 
Solution 1: 2% acetaldehyde in dimethylformamide  
Solution 2: 2% chloranil in dimethylformamide  
A few beads of resin are placed in a small test tube and 2-5 drops of a solution of 2% acetaldehyde in 
dimethylformamide and 2% chloranil in dimethylformamide are added. The mixture is mixed for a short period and 
left at room temperature for 5 min and the color of the beads is observed. A positive result is shown by dark blue to 
green beads and a negative result is shown by colourless to yellowish beads. 
2.6. Thin layer chromatography (TLC) 
A few beads of resin are placed in a small test tube and 5 drops of TFA:dichloromethane (2:8)  was added. The 
mixture was shaken for 5 min. The reaction mixture was spotted on the TLC plate and eluted by eluent of  
chloroform/methanol/acetic acid (90:8:2). The plate was then observed under 254 nm UV light. 
2.7. Reversed-phase flash column chromatography 
Peptide crude were applied on flash column that has been packed with octadecyl-functionalized silica as 
stationary phase. The gradient eluent or mobile phase of methanol:water was employed with the increasing methanol 
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volume and the addition of 1% TFA. Every fraction was spotted on the TLC plate and fractions with similar Rf 
values were combined and characterized with ESI-MS. 
 
3. Results and Discussion 
Synthesis of the linear decapeptide (TMOF) was initiated by attaching the first amino acid, Fmoc-L-proline, onto 
the 2-chlorotrityl resin (Figure 2). This step was undertaken in dichloromethane in the presence of a base, DIPEA. 
The mixture was shaken for 30 minutes to facilitate complete attachment. The resin was found to have an amino 
acid  loading of 0.52 mmol/ 1.00 g resin. 
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Fig. 2. Attachment of the first amino acid, (a) Fmoc-L-Pro, CH2Cl2, DIPEA. 
 
To avoid truncated products, methanol was then added in order to cap any of the remaining chloro groups on the 
resin (Figure 3). This capping would ensure that there was only the amino group of the proline available for the next 
coupling. 
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Fig. 3. Capping the resin, (a) Dichloromethane:methanol:DIPEA (80:15:5). 
 
The next step involved removal of the Fmoc protecting group which took advantage of the basic conditions of 
25% piperidine in DMF for 30 minutes (Figure 4). After washing the resin with DMF and dichloromethane, the 
relatively dry resin was tested before it was ready for coupling with a second amino acid. A few beads of the dry 
resin were tested with a chloranil test with a positive result suggesting the presence of a secondary amino acid due to 
complete removal of the Fmoc protecting group. The few beads of resin were also tested by spotting the cleaved 
peptide on silica gel GF254 plate of thin layer chromatography (TLC) (chloroform:methanol:acetic acid/90:8:2). The 
absence of  fluorescencing spot under 254 nm UV light indicating that the Fmoc group has been completely 
removed. 
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Fig. 4. Fmoc removal, (a) 25% piperidine in DMF, 30 minutes. 
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Coupling of the second amino acid, Fmoc-L-proline, was carried out using a combination of DIC and oxyma as 
coupling reagent (Figure. 5). The coupling system was found to give a complete attachment of the second residue, 
Fmoc-L-proline, after 24 hours coupling. The chloranil test was applied to test the coupling effectiveness. The 
negative test of the chloranil test showing that the coupling was successful. The next step was Fmoc deprotection 
using 25% piperidine in DMF to give the dipeptidyl resin that was ready for the next coupling. The successful 
deprotection was again tested by TLC as before, where the absence of the Fmoc group was shown by the absence of 
the spot on the TLC plate. 
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Fig. 5. Second residue attachment, (a) Fmoc-L-proline, DIC/oxyma, DMF  (b) 25% piperidine in DMF. 
 
The following coupling for respective four Fmoc-L-proline, Fmoc-L-alanine, Fmoc-L-proline, Fmoc-L-aspartic 
acid, and Fmoc-L-tyrosine took advantage of similar repetitive protocol (coupling and Fmoc deprotection) as above.  
It was found that the Fmoc removal step was more difficult when four residues were attached on the resin. A 
single deblocking cycle (1 x 30 min) was not sufficient when 25% piperidine in DMF was employed. 
It must be noted that the side chain of both Fmoc-aspactic acid and Fmoc tyrosine is t-Bu group based. This 
selection was based on the ease of the deprotection of the group during the resin cleavage using TFA. The t-Bu 
group was TFA-labiled. 
The presence of decapeptidyl resin of TMOF was confirmed by ESI-MS. ESI-MS analysis showed a correct 
molecular mass ion of m/z 1047.0, corresponding to the [M+H]+ of the unprotected decapeptide, cleaved from the 
resin. This result showed that the TMOF was successfully synthesised using solid-phase method with DIC/oxyma as 
coupling reagent. This result also suggested that the decapeptide was ready to be cleaved from the resin. 
The cleavage conditions (Figure 6) employed for removal of the decapeptide from the resin were 
TFA:EDT:water (9.5:2.5:2.5). EDT was added into the cocktail in order to scavenge the t-butyl cations of tyrosine. 
The cocktail was added to the unprotected decapeptidyl resin and shaken for 1 hour resulting in the cleaved 
decapeptide. This was observed by the yellow beads turning red, indicating that the decapeptide had been cleaved 
from the resin. The resin was washed with dichloromethane several times with the cleavage cocktail and the 
washings were combined. The solvent was then removed by rotary evaporation at room temperature. This step was 
undertaken several times in order to remove any trace of TFA and EDT.  
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Fig. 6.  Resin cleavage, (a) TFA:EDT:water (9.5:2.5:2.5) over 1 hour. 
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The peptide crude were purified by reversed-phase flash column chromatography and were characterized by 
ESI-MS. The synthesis of analogues PPPP and DPAP were carried out using the same protocol as applied for 
TMOF. However, the resin cleavage of PPPP and DPAP was different with that of TMOF. This was due to the 
absence of any t-Bu protecting in the structure, so that EDT as a t-Bu scavenger, was not needed. A cocktail of 
TFA/dichloromethane was employed instead of a cocktail of TFA/EDT//water. At the end of the synthesis, ESI-MS 
analysis provided the molecular mass ion of m/z 407.3, indicating the [M+H]+ ion of the desired tetrapeptide, PPPP. 
While the synthesised DPAP was confirmed by molecular mass ion of m/z 397, indicating the [M+H]+ ion of the 
desired tetrapeptide, DPAP.  
 
Conclusion 
TMOF and two analogues were successfully synthesised by solid-phase peptide synthesis with DIC/oxyma as 
coupling reagent. The synthesis was carried out on chlorotrityl resin with Fmoc strategy. The peptide crude were 
purified by reverse-phase flash column chromatography and characterized by ESI-MS. In the future, these peptides 
will be assayed against cabbage pest, Crocidolomia pavonana, to test their effectiveness as inhibitor for trypsin 
biosynthesis. 
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